MBRX · Moleculin Biotech, Inc. · Analyst Estimates
$0.48
-0.01 (-1.40%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had an accumulated deficit of $226.5 million since inception and had not yet generated any revenues from operations. Additionally, management anticipates that its cash on hand of $7.3 million as of June 30, 2026, is not sufficient to fund its planned operations for a period of at least one year from when these condensed consolidated financial statements are issued. These factors raise substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$11.72M
Shares
19.48M
Volume · Oct 2
422.27K
Avg daily vol (3M)
1.27M
Analyst Estimates
Compare analyst forecasts for Moleculin Biotech, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 16:31 UTC · Publication dates shown per estimate · 16 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-3.53
|
-3.26667
|
-2.94
|
— |
-5.40667
|
-4.6
|
-3.235
|
-4.6
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
0
|
0
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.61
|
-1.17
|
-0.7
|
— |
-3.84333
|
-3.84333
|
-2.13667
|
-3.84333
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
0
|
0
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.54
|
-0.44333
|
-0.34
|
— |
-1.015
|
-1.07
|
-0.44
|
-1.07
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
0
|
0
|
1
|
2
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 30 days ago | Average, 60 days ago | Average, 7 days ago | Average, 90 days ago | Estimates lowered, last 30 days | Estimates lowered, last 7 days | Estimates raised, last 30 days | Estimates raised, last 7 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.47
|
-0.42667
|
-0.4
|
— |
-0.685
|
-0.26
|
-0.405
|
-0.26
|
— | — | — | — |
|
EPS
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — |
0
|
0
|
1
|
2
|
|
Revenue
USD
Publication date not stated |
0
|
0
|
0
|
— | — | — | — | — | — | — | — | — |
|
Revenue
analysts
Publication date not stated |
— | — | — |
3
|
— | — | — | — | — | — | — | — |